Clinical evaluation of safety and immunogenicity of an indigenously developed purified chick embryo cell rabies vaccine when administered intradermally in animal bite cases

Trial Profile

Clinical evaluation of safety and immunogenicity of an indigenously developed purified chick embryo cell rabies vaccine when administered intradermally in animal bite cases

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Rabies vaccine (Primary)
  • Indications Rabies
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top